08.01.2016

EULAR’s revised fibromyalgia recommendations are more of the same

This story about EULAR's revised fibromyalgia recommendations was originally published on NationalPainReport.com. It is being republished here with permission from the editor. Earlier this month, the European League Against Rheumatism (EULAR) released its revised recommendations for the management of fibromyalgia. Unfortunately, there’s nothing really new about EULAR’s latest report. The group’s main conclusion is something every fibromyalgia sufferer has heard from their physician: “Based on meta-analyses, the only ‘strong for’ therapy-based recommendation in the guidelines was … [Read more...]

07.26.2016

What the research really says about using opioids for fibromyalgia

This story on using opioids for fibromyalgia first published on NationalPainReport.com. It is being reprinted here with permission from the editor.  Using opioids for fibromyalgia My fibromyalgia and primary-care doctors have always been united when it comes to one thing: Opioids do not relieve fibromyalgia pain! Early on, I believed them and didn’t question their treatment plans. I figured they must have formed their opinions based on actual clinical trials. Turns out, I was wrong. The reality is there have been no sizable, randomized, double-blind, placebo-controlled studies to … [Read more...]

07.01.2016

Low-dose naltrexone: An effective treatment for ME/CFS?

The following article on low-dose naltrexone for ME/CFS was first published on Prohealth.com. It is being reprinted here with permission from the editor.  Unlike fibromyalgia, there are no FDA-approved treatments for ME/CFS, leaving few options for relieving symptoms. But in recent years, a growing number of patients have started using a little-known drug called low-dose naltrexone (LDN) as an off-label treatment, and now an Alabama-based researcher is planning the first trial to find out if LDN actually reduces the symptoms of ME/CFS. The FDA approved naltrexone to treat addiction to … [Read more...]

05.26.2016

Three new fibromyalgia drugs could be on the way

The following article on new fibromyalgia drugs was first published on NationalPainReport.com and is being reprinted here with permission from the editor. Updated 9/26/16 During the year following my fibromyalgia diagnosis, my rheumatologist prescribed five different drugs in an attempt to relieve my pain. None of them worked. The current fibromyalgia drugs on the market are notoriously ineffective. I remember my rheumatologist sharing a surprising statistic that I’ve since verified through my own research: The most effective fibromyalgia drugs only provide at least a 50 … [Read more...]

05.18.2016

IMC-1 antiviral combo may be next blockbuster fibromyalgia drug

This story on Dr. William "Skip" Pridgen's IMC-1 fibromyalgia drug combination was first published on NationalPainReport.com and is being reprinted here with permission from the editor.  Is IMC-1 the next big thing? A general surgeon with a small practice in Tuscaloosa, Alabama, Dr. William “Skip” Pridgen admits he’s an unlikely creator for the next blockbuster fibromyalgia drug. But the U.S. Food and Drug Administration (FDA) has fast tracked Pridgen’s novel pairing of famciclovir (Famvir), a common antiviral, with celecoxib (Celebrex), an anti-inflammatory arthritis drug, for a … [Read more...]

04.06.2016

More insurance companies now paying for FM/a fibromyalgia test

The story below on the FM/a fibromyalgia test first appeared on NationalPainReport.com. It is being republished here with permission from the editor. (Note: I have no financial interest in EpicGenetics or the FM/a fibromyalgia test.)  Do you have a family member, friend or physician who doubts you have fibromyalgia? Well, there’s a little-known test you may not have heard of that could finally prove you’re really sick. In 2013, Los Angeles-based biomedical company EpicGenetics made international headlines when it introduced FM/a, the first ever fibromyalgia test. While FM/a hasn’t … [Read more...]

02.04.2016

Cymbalta’s withdrawal symptoms prompt lawsuits

As my long-time readers know, I've been closely following the lawsuits related to Cymbalta's withdrawal symptoms on FedUpwithFatigue.com. I was recently asked by Prohealth.com to update their readers on the Cymbalta lawsuits. I'm reprinting that story here with the editor's permission.  I've created a special resources page for anyone interested in Cymbalta's withdrawal symptoms and the pending lawsuits. It includes all of FedUpwithFatigue’s Cymbalta-related posts, links to news stories, support groups and other useful information. Update 10/25/16: The Cymbalta lawsuits have been … [Read more...]

12.12.2015

Naltrexone “changed life” of fibromyalgia patient

My regular readers know I'm a big fan of using low dose naltrexone for fibromyalgia. I recently had the opportunity to write about LDN and how it's becoming an emerging fibromyalgia treatment for Pain News Network. The story includes interviews with Jarred Younger, the researcher who conducted the first two LDN/fibromyalgia studies at Stanford University (more studies are on the way!), and Linda Elsegood, founder of the LDN Research Trust. I'm reprinting the story here with Pain News Network's permission. The pain in Janice Hollander’s legs was so excruciating that she wanted to cut … [Read more...]

11.23.2015

A timeline of the Cymbalta lawsuits

This is Part 3 of an ongoing series on the Cymbalta withdrawal lawsuits. It includes a timeline of the cases that have gone to court so far and their outcomes. I've included links to news stories on the cases wherever possible. Unfortunately, the mainstream media hasn't paid much attention to the Cymbalta lawsuits, so many of the links come from Law360, a subscription-based legal news service. For readers who really want to delve into the details of these cases, I would suggest signing up for a free trial of Law360 and then brewing a big pot of tea or coffee because you'll be reading for a few … [Read more...]

10.23.2015

The Cymbalta withdrawal lawsuits: An interview with the attorneys

This is Part 2 of an ongoing series on the Cymbalta withdrawal lawsuits. It includes an interview with Baum, Hedlund, Aristei & Goldman, PC, one of the law firms representing hundreds of patients who have been affected by Cymbalta's withdrawal symptoms. Part 1 of this series addressed Cymbalta's withdrawal symptoms, why the lawsuits were brought and helpful information for anyone planning to stop Cymbalta. Next month, I'll be writing a follow-up post summarizing the cases that have been heard so far and their outcomes. As always, I'll post any news related to the lawsuits in my weekly news … [Read more...]

Wordpress content guard plugin by JaspreetChahal.org